These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
548 related articles for article (PubMed ID: 10854221)
1. INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene. Pinyol M; Hernández L; Martínez A; Cobo F; Hernández S; Beà S; López-Guillermo A; Nayach I; Palacín A; Nadal A; Fernández PL; Montserrat E; Cardesa A; Campo E Am J Pathol; 2000 Jun; 156(6):1987-96. PubMed ID: 10854221 [TBL] [Abstract][Full Text] [Related]
2. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma. Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936 [TBL] [Abstract][Full Text] [Related]
3. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835 [TBL] [Abstract][Full Text] [Related]
4. Quantitative real-time PCR does not show selective targeting of p14(ARF) but concomitant inactivation of both p16(INK4A) and p14(ARF) in 105 human primary gliomas. Labuhn M; Jones G; Speel EJ; Maier D; Zweifel C; Gratzl O; Van Meir EG; Hegi ME; Merlo A Oncogene; 2001 Mar; 20(9):1103-9. PubMed ID: 11314047 [TBL] [Abstract][Full Text] [Related]
5. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck. Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502 [TBL] [Abstract][Full Text] [Related]
6. Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia. Kresty LA; Mallery SR; Knobloch TJ; Song H; Lloyd M; Casto BC; Weghorst CM Cancer Res; 2002 Sep; 62(18):5295-300. PubMed ID: 12234999 [TBL] [Abstract][Full Text] [Related]
7. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas. Nakamura M; Sakaki T; Hashimoto H; Nakase H; Ishida E; Shimada K; Konishi N Cancer Res; 2001 Sep; 61(17):6335-9. PubMed ID: 11522621 [TBL] [Abstract][Full Text] [Related]
8. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland. Weber A; Langhanki L; Schütz A; Wittekind C; Bootz F; Tannapfel A J Pathol; 2002 Nov; 198(3):326-34. PubMed ID: 12375265 [TBL] [Abstract][Full Text] [Related]
9. Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas. Ito T; Nishida N; Fukuda Y; Nishimura T; Komeda T; Nakao K J Gastroenterol; 2004; 39(4):355-61. PubMed ID: 15168247 [TBL] [Abstract][Full Text] [Related]
10. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis. Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779 [TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma. Edmunds SC; Kelsell DP; Hungerford JL; Cree IA Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501 [TBL] [Abstract][Full Text] [Related]
12. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer. Sanchez-Cespedes M; Reed AL; Buta M; Wu L; Westra WH; Herman JG; Yang SC; Jen J; Sidransky D Oncogene; 1999 Oct; 18(43):5843-9. PubMed ID: 10557071 [TBL] [Abstract][Full Text] [Related]
13. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma. Sailasree R; Abhilash A; Sathyan KM; Nalinakumari KR; Thomas S; Kannan S Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):414-20. PubMed ID: 18268126 [TBL] [Abstract][Full Text] [Related]
14. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation. Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918 [TBL] [Abstract][Full Text] [Related]
15. Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression. Villuendas R; Sánchez-Beato M; Martínez JC; Saez AI; Martinez-Delgado B; García JF; Mateo MS; Sanchez-Verde L; Benítez J; Martínez P; Piris MA Am J Pathol; 1998 Sep; 153(3):887-97. PubMed ID: 9736037 [TBL] [Abstract][Full Text] [Related]
16. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma. Tannapfel A; Sommerer F; Benicke M; Weinans L; Katalinic A; Geissler F; Uhlmann D; Hauss J; Wittekind C J Pathol; 2002 Aug; 197(5):624-31. PubMed ID: 12210082 [TBL] [Abstract][Full Text] [Related]
17. Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis. Oda Y; Yamamoto H; Takahira T; Kobayashi C; Kawaguchi K; Tateishi N; Nozuka Y; Tamiya S; Tanaka K; Matsuda S; Yokoyama R; Iwamoto Y; Tsuneyoshi M J Pathol; 2005 Dec; 207(4):410-21. PubMed ID: 16177957 [TBL] [Abstract][Full Text] [Related]
18. Relationship between alterations of p16(INK4a) and p14(ARF) genes of CDKN2A locus and gastric carcinogenesis. Tang S; Luo H; Yu J; Yang D; Shu J Chin Med J (Engl); 2003 Jul; 116(7):1083-7. PubMed ID: 12890389 [TBL] [Abstract][Full Text] [Related]
19. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924 [TBL] [Abstract][Full Text] [Related]
20. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines. Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]